Itau Unibanco Holding S.A. Bluebird Bio, Inc. Transaction History

Itau Unibanco Holding S.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.32 - $4.83 $3,313 - $12,123	-2,510 Reduced 34.02%	4,868 $6,000
Q3 2023 Nov 14, 2023	BUY	$3.02 - $4.05 $5,478 - $7,346	1,814 Added 32.6%	7,378 $22,000
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $8,515 - $15,351	3,052 Added 121.5%	5,564 $18,000
Q4 2022 Feb 09, 2023	BUY	$5.77 - $8.49 $14,494 - $21,326	2,512 New	2,512 $17,000
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $26,398 - $46,960	8,979 New	8,979 $37,000
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $14,088 - $18,501	-300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $13,727 - $19,043	-181 Reduced 37.63%	300 $38,000
Q4 2018 Feb 13, 2019	BUY	$59.1 - $93.26 $10,697 - $16,880	181 Added 60.33%	481 $46,000
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $6,220 - $8,224	70 Added 30.43%	300 $44,000
Q2 2018 Aug 13, 2018	SELL	$99.64 - $127.59 $199 - $255	-2 Reduced 0.86%	230 $36,000
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $13,225 - $18,867	125 Added 116.82%	232 $40,000
Q4 2017 Feb 09, 2018	SELL	$81.25 - $130.7 $893 - $1,437	-11 Reduced 9.32%	107 $19,000
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $6,813 - $10,787	118	118 $51,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.